Ignite Creation Date:
2025-12-24 @ 10:01 PM
Ignite Modification Date:
2026-02-25 @ 5:34 PM
Study NCT ID:
NCT02758132
Status:
TERMINATED
Last Update Posted:
2019-11-08
First Post:
2016-04-11
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases
Sponsor:
University of Hawaii
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-06
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-11
First Submit QC Date:
None
Study First Post Date:
2016-05-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-09-10
Results First Submit QC Date:
None
Results First Post Date:
2019-10-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-06
Last Update Post Date:
2019-11-08
Last Update Post Date Type:
ACTUAL